Four Swiss-based companies will received state funding to develop a range of new drugs to treat coronavirus, which are expected to be available by the end of 2022.
This content was published on
1 minute
swissinfo.ch/dos
Português
pt
Governo suíço financia quatro novos medicamentos contra a Covid
The contracts were signed in the context of the Federal Funding Programme for Covid-19 Medicines, run by the Federal Office for Public Health (FOPH) and the Swiss Innovation Agency Innosuisse, the government said on MondayExternal link.
The total value of the four deals is CHF27 million ($29.2 million).
The projects aim to treat a range of the symptoms caused by a Covid-19 infection and to mitigate the length and severity of illness.
Two of the drugs are monoclonal antibody treatments: one for the neuropsychiatric symptoms in sufferers of long Covid, and the other for use on patients at risk of a severe course of Covid-19. A third project is developing an oral pulmonary vasodilator which makers hope will prevent respiratory failure and reduce the need for artificial ventilation.
A final project is an antiviral and anti-inflammatory to treat “all severities of Covid-19”.
Switzerland will enjoy “certain benefits” in return for its investment, the government stated. This includes having a first option on purchases of the drugs.
The government’s medical procurement capabilities to tackle the coronavirus pandemic come under the remit of the Covid-19 law, approved for a second time by voters in a nationwide referendum two weeks ago.
More
More
Coronavirus: the situation in Switzerland
This content was published on
An overview of the latest Covid-related information in the Alpine nation.
This content was published on
The cantonal parliament of Vaud has approved a loan of CHF9.5 million ($11.5 million) for Château de Chillon, the most-visited monument in Switzerland.
Swiss party president Thierry Burkart to step down in October
This content was published on
Thierry Burkart, president of the centre-right Radical-Liberal Party, wants to hand over the presidency in October, around two years before the next national elections.
Climate Alliance presents action plan on 20th anniversary
This content was published on
The Swiss Climate Alliance has presented an action plan showing how Switzerland could make a success of the energy transition and achieve a net zero balance within ten years.
Swiss business group expects export slump after strong start to year
This content was published on
The Swiss economy was still robust in the first quarter of 2025 but is coming under increasing pressure, says the Swiss business federation, economiesuisse.
Five arrested in Switzerland in human-trafficking raid
This content was published on
Law enforcement authorities in Switzerland and Romania have busted a human trafficking ring. They arrested a total of 17 suspects.
OECD significantly lowers Swiss GDP forecast due to Trump
This content was published on
The Swiss economy is likely to grow more slowly in 2025 and 2026 than previously assumed, according to the OECD economic organisation.
UBS economists more confident about Swiss economy in 2025
This content was published on
UBS economists have revised upwards their estimates of Swiss GDP growth for the current year. However, they are more pessimistic for next year, due to the spectre of US tariffs.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
It’s not all about age: why Covid hits some people harder than others
This content was published on
New insights: two studies involving Swiss scientists suggest genes and blood sugar levels play a crucial role in the course of Covid-19.
This content was published on
Should we be afraid of virus variants? Will vaccines be effective against new virus forms? Genomic epidemiologist Emma Hodcroft offers some insight.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.